BioCentury | May 11, 2018
Company News

Merck, J&J vaccines ready for Ebola outbreak

...a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier from Aethlon Medical Inc....
...from CanSino Biologics Inc. (Tianjin, China), is approved in China to treat Ebola virus infection. Aethlon Medical Inc....
...Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Infectious Chris Lieu Ad26.ZEBOV Ad5-EBOV Aethlon Hemopurifier (Hemopurifier) MVA-BN Filo VSV-EBOV (V920, BPSC1001, rVSV-EBOV, rVSV-ZEBOV-GP, VSV-ZEBOV) Aethlon Medical Inc. CanSino...
BioCentury | May 9, 2018
Politics & Policy

Merck, J&J vaccines ready for Ebola outbreak

...a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier from Aethlon Medical Inc....
...in China to treat Ebola virus infection. Chris Lieu Ad26.ZEBOV Ad5-EBOV Aethlon Hemopurifier (Hemopurifier) MVA-BN Filo VSV-EBOV (V920, BPSC1001, rVSV-EBOV, rVSV-ZEBOV-GP, VSV-ZEBOV) Aethlon Medical Inc. CanSino...
BioCentury | Oct 13, 2016
Strategy

Exosomes in the zone

...have also secured grant funding to advance the technology. Exosome Sciences Inc., a subsidiary of Aethlon Medical Inc....
...low-hanging fruit that we can move on fairly quickly," said Williams. Companies and Institutions Mentioned Aethlon Medical Inc....
...Feb. 2012 DxS Ltd. (now part of Qiagen) June 2009 Exosome Sciences Inc., subsidiary of Aethlon Medical Inc....
BioCentury | Aug 22, 2016
Clinical News

Aethlon Medical preclinical data

...approved a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier. Aethlon Medical Inc....
BioCentury | Aug 18, 2016
Translation in Brief

Streaming exosomes

...million in a series B round, having raised $20 million in 2010. In October 2013, Aethlon Medical Inc....
BioCentury | Feb 15, 2016
Emerging Company Profile

Platelet portrait

...isolates platelets." According to the literature, there is no standard procedure for exosome isolation. However, Aethlon Medical Inc....
...thromboDx is looking for partners to co-develop and commercialize the technology. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | Dec 10, 2015
Product R&D

Stem and deliver

...far, the commercial focus for exosomes has been primarily in oncology. Exosome Diagnostics Inc. and Aethlon Medical Inc....
..."Part of NCATS's mission is really being a catalyst," he said. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | Nov 23, 2015
Emerging Company Profile

Exosome exploitation

...diagnostics. The newco also will study the biomarker in other tumors. Exosome Diagnostics Inc. and Aethlon Medical Inc....
...the power of exosomes for a variety of payloads," he said. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | Oct 1, 2015
Tools & Techniques

NCATS's extracellular revolution

...already doing it," he told BioCentury. Several companies, including Exosome Sciences Inc., a subsidiary of Aethlon Medical Inc....
...to melanoma, lung cancer, breast cancer and colorectal cancer, Skog said. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | May 11, 2015
Financial News

Aethlon Medical withdraws follow-on

Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Business: Infectious, Cancer Date announced: 2015-05-01 Type: Follow-on Underwriter: Roth Capital Partners Note: Aethlon withdrew its follow-on, citing market conditions. WIR Staff cancer Infectious...
Items per page:
1 - 10 of 29
BioCentury | May 11, 2018
Company News

Merck, J&J vaccines ready for Ebola outbreak

...a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier from Aethlon Medical Inc....
...from CanSino Biologics Inc. (Tianjin, China), is approved in China to treat Ebola virus infection. Aethlon Medical Inc....
...Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Infectious Chris Lieu Ad26.ZEBOV Ad5-EBOV Aethlon Hemopurifier (Hemopurifier) MVA-BN Filo VSV-EBOV (V920, BPSC1001, rVSV-EBOV, rVSV-ZEBOV-GP, VSV-ZEBOV) Aethlon Medical Inc. CanSino...
BioCentury | May 9, 2018
Politics & Policy

Merck, J&J vaccines ready for Ebola outbreak

...a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier from Aethlon Medical Inc....
...in China to treat Ebola virus infection. Chris Lieu Ad26.ZEBOV Ad5-EBOV Aethlon Hemopurifier (Hemopurifier) MVA-BN Filo VSV-EBOV (V920, BPSC1001, rVSV-EBOV, rVSV-ZEBOV-GP, VSV-ZEBOV) Aethlon Medical Inc. CanSino...
BioCentury | Oct 13, 2016
Strategy

Exosomes in the zone

...have also secured grant funding to advance the technology. Exosome Sciences Inc., a subsidiary of Aethlon Medical Inc....
...low-hanging fruit that we can move on fairly quickly," said Williams. Companies and Institutions Mentioned Aethlon Medical Inc....
...Feb. 2012 DxS Ltd. (now part of Qiagen) June 2009 Exosome Sciences Inc., subsidiary of Aethlon Medical Inc....
BioCentury | Aug 22, 2016
Clinical News

Aethlon Medical preclinical data

...approved a clinical protocol to treat Ebola-infected patients in the U.S. with the Aethlon Hemopurifier. Aethlon Medical Inc....
BioCentury | Aug 18, 2016
Translation in Brief

Streaming exosomes

...million in a series B round, having raised $20 million in 2010. In October 2013, Aethlon Medical Inc....
BioCentury | Feb 15, 2016
Emerging Company Profile

Platelet portrait

...isolates platelets." According to the literature, there is no standard procedure for exosome isolation. However, Aethlon Medical Inc....
...thromboDx is looking for partners to co-develop and commercialize the technology. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | Dec 10, 2015
Product R&D

Stem and deliver

...far, the commercial focus for exosomes has been primarily in oncology. Exosome Diagnostics Inc. and Aethlon Medical Inc....
..."Part of NCATS's mission is really being a catalyst," he said. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | Nov 23, 2015
Emerging Company Profile

Exosome exploitation

...diagnostics. The newco also will study the biomarker in other tumors. Exosome Diagnostics Inc. and Aethlon Medical Inc....
...the power of exosomes for a variety of payloads," he said. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | Oct 1, 2015
Tools & Techniques

NCATS's extracellular revolution

...already doing it," he told BioCentury. Several companies, including Exosome Sciences Inc., a subsidiary of Aethlon Medical Inc....
...to melanoma, lung cancer, breast cancer and colorectal cancer, Skog said. Companies and Institutions Mentioned Aethlon Medical Inc....
BioCentury | May 11, 2015
Financial News

Aethlon Medical withdraws follow-on

Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Business: Infectious, Cancer Date announced: 2015-05-01 Type: Follow-on Underwriter: Roth Capital Partners Note: Aethlon withdrew its follow-on, citing market conditions. WIR Staff cancer Infectious...
Items per page:
1 - 10 of 29